Zevra Therapeutics Inc (ZVRA)
9.03
+0.37
(+4.27%)
USD |
NASDAQ |
Nov 14, 16:00
9.015
-0.02
(-0.17%)
After-Hours: 20:00
Zevra Therapeutics Free Cash Flow (Quarterly): -19.11M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -19.11M |
March 31, 2024 | -16.16M |
December 31, 2023 | -16.23M |
September 30, 2023 | -4.80M |
June 30, 2023 | -8.727M |
March 31, 2023 | -4.074M |
December 31, 2022 | -4.496M |
September 30, 2022 | -6.626M |
June 30, 2022 | -4.119M |
March 31, 2022 | -3.569M |
December 31, 2021 | -0.865M |
September 30, 2021 | -2.734M |
June 30, 2021 | 16.52M |
March 31, 2021 | -2.586M |
December 31, 2020 | -1.085M |
September 30, 2020 | -1.051M |
June 30, 2020 | 2.197M |
March 31, 2020 | -2.033M |
December 31, 2019 | -3.103M |
September 30, 2019 | -2.233M |
June 30, 2019 | -7.344M |
Date | Value |
---|---|
March 31, 2019 | -11.08M |
December 31, 2018 | -15.01M |
September 30, 2018 | -15.96M |
June 30, 2018 | -9.152M |
March 31, 2018 | -14.10M |
December 31, 2017 | -6.939M |
September 30, 2017 | -10.20M |
June 30, 2017 | -6.517M |
March 31, 2017 | -9.62M |
December 31, 2016 | -9.449M |
September 30, 2016 | -8.608M |
June 30, 2016 | -8.427M |
March 31, 2016 | -3.931M |
December 31, 2015 | -6.443M |
September 30, 2015 | -4.666M |
June 30, 2015 | -5.274M |
March 31, 2015 | -4.02M |
December 31, 2014 | -6.991M |
September 30, 2014 | -3.894M |
June 30, 2014 | -2.941M |
March 31, 2014 | -0.892M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.11M
Minimum
Jun 2024
16.52M
Maximum
Jun 2021
-4.350M
Average
-3.569M
Median
Mar 2022
Free Cash Flow (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | -111.30M |
Vanda Pharmaceuticals Inc | -14.74M |
BioCardia Inc | -1.315M |
Xeris Biopharma Holdings Inc | -8.392M |
Instil Bio Inc | -10.61M |